Why the study?
Does beta-blocker monotherapy improve blood pressure normalization in patients with essential hypertension based on age and renin levels?
Does beta-blocker monotherapy improve blood pressure normalization in patients with essential hypertension based on age and renin levels?
Beta-blocker monotherapy is most effective for hypertension in younger patients and those with high renin levels, suggesting a targeted approach to antihypertensive therapy.
Answers are grounded in this paper and cite their sources.
May support age- and renin-stratified beta-blocker use in hypertension; leaves open prospective randomized confirmation.
From analyses of the effectiveness of beta-blocker monotherapy in relation to the patient's age and to pre-treatment renin determinations an antihypertensive drug program is proposed in which beta-blockers form the cornerstone. Patients with essential hypertension can be subdivided into groups with low (19%), normal (59%), or high (23%) renin sodium index. The proportion with low renin hypertension increases with age. Patients with high renin fall into two categories: younger patients with fairly mild hypertension and older pateients with more severe hypertension and signs of renal disease. The antihypertensive efficacy of beta-blocker monotherapy is best in high renin forms, good but less consistent in normal renin patients and uniformly bad in low renin hypertensives. In relation to age, beta-blockers normalized blood pressure (larger than or equal to 95 mmHg diastolic) in three-quarters of the younger than 40-year-olds, in about half of those aged 40--60 years, but in only 20% of those aged over 60 years. On this basis, it is postulated that the older patients with a low renin exhibit a relatively hypoadrenergic state while those with a normal or high renin--for a given age and elevated pressure--have a relatively increased adrenergic nervous activity. Because the beta-blockers have a potent suppressive action on the renin-angiotensin system--and, as a consequence, on angiotensin vasoconstriction, aldosterone volume expansion and central stimulatory feedback mechanisms--their antihypertensive mode of action may be linked to an important extent, though not exclusively, to renin suppression.
No takes yet. Share an insight, caveat, or question.
Bühler et al. (1976) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: